The South Texas Aging Registry and Repository

Aging Clinical Trial

— STARR  

Official title:

The South Texas Aging Registry and Repository (STARR)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05835388
• Other study ID #: HSC20150610H
• Status: Completed
• Start date: February 11, 2019
• Est. completion date: December 6, 2023

Study information

• Verified date: May 2024
• Source: The University of Texas Health Science Center at San Antonio
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This research registry and repository was designed because the investigators want to learn about how to improve the health and quality of life of older adults.

Description:

The South Texas Aging Registry and Repository (STARR) is a database and specimen resource of community dwelling adults from the South Texas area who are interested in volunteering for research studies on aging. The goal is to assist in the inclusion of older adults in clinical research studies and to help to increase the quantity and quality of research relating to them. This registry and repository can be used for various purposes ranging from describing the natural history of aging, identifying risk factors for premature aging, and the real-world effectiveness of life-extending therapies. Collection and storage of biological samples and patient-reported data from of Individuals can help advance research and the development of new awareness of basic mechanisms that play a part in healthy aging or premature death.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 149
• Est. completion date: December 6, 2023
• Est. primary completion date: December 6, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria STARR:

-Age 18 years or older

Inclusion Criteria KAPP Sen TMC:

-Age 20 years and older

Exclusion Criteria STARR:

• Inability to provide informed consent

• Pregnancy

Exclusion Criteria KAPP Sen Tissue Mapping Center (TMC) Study:

• Diabetes

• Hypertension with end-organ damage

• BMI>30

• GFR<60 ml/min/1.73 m2

• Cardiovascular disease

• Pancreatitis

• Malignancy other than non-melanoma skin cancers

• Active, uncontrolled pulmonary, hepatic, infectious, gastrointestinal, endocrine, neurologic, or inflammatory disease.

• Chronic use of systemic steroids or use of agents with senolytic activity

• Any disease or condition considered to be exclusionary based on the clinical option and discretion of PI

Related Conditions & MeSH terms

• Aging

Locations

Country	Name	City	State
United States	The University of Texas Health Science Center at San Antonio	San Antonio	Texas

Sponsors (1)

Lead Sponsor	Collaborator
The University of Texas Health Science Center at San Antonio

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Collection of STARR repository data	De-identified repository data and samples will be made available to outside investigators for future studies related to aging	Baseline to one day
Secondary	KAPP Sen TMC repository data	Eligible STARR participants to undergo repeat assessments to characterize cellular senescence	Baseline to one year